1763 — China Isotope & Radiation Income Statement
0.000.00%
Last trade - 00:00
- HK$3.46bn
- HK$4.81bn
- CNY6.63bn
- 45
- 90
- 32
- 60
2019 December 31st | C2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | IFRS | IFRS | IFRS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,989 | 4,274 | 5,144 | 6,154 | 6,635 |
Cost of Revenue | |||||
Gross Profit | 2,829 | 2,616 | 3,242 | 3,518 | 3,482 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,268 | 3,659 | 4,366 | 5,240 | 5,693 |
Operating Profit | 721 | 615 | 778 | 914 | 942 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 734 | 596 | 803 | 921 | 922 |
Provision for Income Taxes | |||||
Net Income After Taxes | 625 | 476 | 673 | 755 | 776 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 329 | 214 | 336 | 392 | 371 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 329 | 214 | 336 | 392 | 371 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.04 | 0.681 | 1.04 | 1.27 | 1.16 |
Dividends per Share |